Copertina

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Els D. Bakker, Ingrid S. van Maurik, Marissa D. Zwan, Freek Gillissen, Pieter J. van der Veere, Femke H. Bouwman, Yolande A. L. Pijnenburg, Wiesje M. van der Flier
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Long‐term cost‐effectiveness of a more accurate diagnostic work‐up for dementia
di: Pieter J. van der Veere, et al.
Pubblicazione: (2025)

Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting
di: Rebecca Z. Rousset, et al.
Pubblicazione: (2024)

Survey among experts on the future role of tau‐PET in clinical practice and trials
di: Marie R. Vermeiren, et al.
Pubblicazione: (2024)

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
di: Angela van der Putten‐Toorenburg, et al.
Pubblicazione: (2026)

Autonomic dysfunction and hypothalamic atrophy in frontotemporal dementia and primary psychiatric disorders
di: Yannick S. S. Timar, et al.
Pubblicazione: (2026)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
di: Robert Perneczky, et al.
Pubblicazione: (2025)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
di: Rosanne L. van den Berg, et al.
Pubblicazione: (2025)

Exploring neuropsychiatric and behavioral symptoms, and social cognitive deficits in the differential diagnosis of behavioral variant of frontotemporal dementia and primary psychiatric disorders: A systematic literature review
di: Femke G. van Dijk, et al.
Pubblicazione: (2026)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
di: Thomas Claessen, et al.
Pubblicazione: (2025)

Commentary: Can an effective end‐of‐life intervention for advanced dementia be viewed as moral?
di: Trijntje M. Scheeres‐Feitsma, et al.
Pubblicazione: (2024)

Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
di: Ayesha Fawad, et al.
Pubblicazione: (2026)

Speech and language features as indicators of neuropsychiatric symptoms in a memory clinic population
di: Zampeta‐Sofia Alexopoulou, et al.
Pubblicazione: (2025)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
di: Marijke E. Stokkel, et al.
Pubblicazione: (2026)

Plasma p‐tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach
di: Giorgia Brodini, et al.
Pubblicazione: (2026)

BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
di: Kyle J. Edmunds, et al.
Pubblicazione: (2025)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
di: Willa D. Brenowitz, et al.
Pubblicazione: (2026)

Brief webcam test of hand movements predicts episodic memory, executive function, and working memory in a community sample of cognitively asymptomatic older adults
di: Renjie Li, et al.
Pubblicazione: (2024)

Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
di: Thomas Claessen, et al.
Pubblicazione: (2026)

Social genomics, cognition, and well‐being during the COVID‐19 pandemic
di: James R. Bateman, et al.
Pubblicazione: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
di: Russell Banks, et al.
Pubblicazione: (2024)

Subjective memory concerns and AD/ADRD plasma biomarker associations in HABS‐HD
di: Kelsey R. Thomas, et al.
Pubblicazione: (2026)

Ethics of disclosure of onset‐predictive biomarker test results for genetic frontotemporal dementia in the research context
di: Charlotte H. Graafland, et al.
Pubblicazione: (2025)

Effect of antipsychotic medication use and type on mortality and cardiovascular risks in nursing home patients with dementia
di: Hamid R. Okhravi, et al.
Pubblicazione: (2026)

Vitamin B6 and vitamin D deficiency co‐occurrence in geriatric memory patients
di: Anna G. Przybelski, et al.
Pubblicazione: (2024)

Health literacy, but not memory, is associated with hippocampal connectivity in adults with low levels of formal education
di: Elisa de Paula França Resende, et al.
Pubblicazione: (2024)

P‐tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study
di: Samantha C. Burnham, et al.
Pubblicazione: (2025)

Hallucinations and delusions are associated with elevated tau PET signal independent of age, clinical severity, and amyloid burden
di: Aubrey S Johnson, et al.
Pubblicazione: (2026)

The role of cerebrovascular reactivity on brain activation during a working memory task in type 2 diabetes
di: Yarden Oliel, et al.
Pubblicazione: (2025)

Sex‐specific blood biomarkers linked to memory changes in middle‐aged adults: The Framingham Heart Study
di: Huitong Ding, et al.
Pubblicazione: (2024)

The Rapid Naming Test: Neuroanatomical validity and clinical utility
di: Kelly J. Atkins, et al.
Pubblicazione: (2025)

Toward alpha‐synuclein seed amplification assay in clinical practice
di: Mathieu Verdurand, et al.
Pubblicazione: (2025)

Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts
di: Tamao Tsukie, et al.
Pubblicazione: (2025)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
di: Steffi De Meyer, et al.
Pubblicazione: (2025)

Neurofilament light chain concentration mediates the association between regional medial temporal lobe structure and memory in adults with Down syndrome
di: Natalie DiProspero, et al.
Pubblicazione: (2024)

Long‐term Alzheimer's disease mortality prediction in adults aged ≥60 years: A prospective cohort study benchmarking survival machine learning algorithms
di: Xiaoping Huang, et al.
Pubblicazione: (2025)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
di: Frederikke Kragh Clemmensen, et al.
Pubblicazione: (2026)

Influence of cognitive, neuropsychiatric, and diagnostic factors on financial capacity: A longitudinal analysis of the ADNI cohort
di: Milap A. Nowrangi, et al.
Pubblicazione: (2025)

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
di: Sonja M. Kagerer, et al.
Pubblicazione: (2024)

Impairments in knowledge of social norms in presymptomatic, prodromal, and symptomatic frontotemporal dementia
di: Liset de Boer, et al.
Pubblicazione: (2024)

Accuracy of clinical diagnosis of behavioral variant frontotemporal dementia: A systematic review and meta‐analysis
di: Daniele Urso, et al.
Pubblicazione: (2026)